These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 1373795

  • 1. Functional interactions between two Ca2+ channel activators, (S)-Bay K 8644 and FPL 64176, in smooth muscle.
    Rampe D, Dage RC.
    Mol Pharmacol; 1992 Apr; 41(4):599-602. PubMed ID: 1373795
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the in vitro and in vivo cardiovascular effects of two structurally distinct Ca++ channel activators, BAY K 8644 and FPL 64176.
    Rampe D, Anderson B, Rapien-Pryor V, Li T, Dage RC.
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1125-30. PubMed ID: 7685384
    [Abstract] [Full Text] [Related]

  • 3. Allosteric interactions at L-type calcium channels between FPL 64176 and the enantiomers of the dihydropyridine Bay K 8644.
    Usowicz MM, Gigg M, Jones LM, Cheung CW, Hartley SA.
    J Pharmacol Exp Ther; 1995 Nov; 275(2):638-45. PubMed ID: 7473149
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel nondihydropyridine Ca2+ channel activator, in cardiac and vascular preparations.
    Zheng W, Rampe D, Triggle DJ.
    Mol Pharmacol; 1991 Nov; 40(5):734-41. PubMed ID: 1719369
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the effects of a new Ca2+ channel activator, FPL 64176, in GH3 cells.
    Kunze DL, Rampe D.
    Mol Pharmacol; 1992 Oct; 42(4):666-70. PubMed ID: 1279375
    [Abstract] [Full Text] [Related]

  • 6. Quercetin antagonism of Bay K 8644 effects on rat tail artery L-type Ca(2+) channels.
    Saponara S, Sgaragli G, Fusi F.
    Eur J Pharmacol; 2008 Nov 19; 598(1-3):75-80. PubMed ID: 18789318
    [Abstract] [Full Text] [Related]

  • 7. Effect of the Ca(2+)-channel agonist Bay K 8644 on the contractile responses in human placental veins.
    Barrús MT, Reviriego J, Marín J.
    J Auton Pharmacol; 1996 Jun 19; 16(3):161-7. PubMed ID: 8884463
    [Abstract] [Full Text] [Related]

  • 8. Voltage-dependent calcium current and the effects of adrenergic modulation in rat aortic smooth muscle cells.
    Serebryakov V, Takeda K.
    Philos Trans R Soc Lond B Biol Sci; 1992 Jul 29; 337(1279):37-47. PubMed ID: 1381837
    [Abstract] [Full Text] [Related]

  • 9. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
    Zahradníková A, Minarovic I, Zahradník I.
    J Pharmacol Exp Ther; 2007 Aug 29; 322(2):638-45. PubMed ID: 17475903
    [Abstract] [Full Text] [Related]

  • 10. Pharmacologic and radioligand binding analysis of the actions of 1,4-dihydropyridine activator-antagonist pairs in smooth muscle.
    Wei XY, Luchowski EM, Rutledge A, Su CM, Triggle DJ.
    J Pharmacol Exp Ther; 1986 Oct 29; 239(1):144-53. PubMed ID: 2428971
    [Abstract] [Full Text] [Related]

  • 11. Modulation of single channels underlying hippocampal L-type current enhancement by agonists depends on the permeant ion.
    Tavalin SJ, Shepherd D, Cloues RK, Bowden SE, Marrion NV.
    J Neurophysiol; 2004 Aug 29; 92(2):824-37. PubMed ID: 15056682
    [Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo vascular responses to the L-type calcium channel activator, Bay K 8644, in rats with cirrhosis.
    Moreau R, Oberti F, Lahaye P, Gadano A, Cailmail S, Sogni P, Cales P, Lebrec D.
    J Gastroenterol Hepatol; 1998 Dec 29; 13(12):1254-8. PubMed ID: 9918435
    [Abstract] [Full Text] [Related]

  • 13. L-type Ca2+ channels activation and contraction elicited by myricetin on vascular smooth muscles.
    Fusi F, Saponara S, Frosini M, Gorelli B, Sgaragli G.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec 29; 368(6):470-8. PubMed ID: 14618297
    [Abstract] [Full Text] [Related]

  • 14. Effects of quercetin and rutin on vascular preparations: a comparison between mechanical and electrophysiological phenomena.
    Fusi F, Saponara S, Pessina F, Gorelli B, Sgaragli G.
    Eur J Nutr; 2003 Jan 29; 42(1):10-7. PubMed ID: 12594537
    [Abstract] [Full Text] [Related]

  • 15. Phorbol ester-stimulated bidirectional transmembrane calcium flux in A7r5 vascular smooth muscle cells.
    Sperti G, Colucci WS.
    Mol Pharmacol; 1987 Jul 29; 32(1):37-42. PubMed ID: 2439892
    [Abstract] [Full Text] [Related]

  • 16. [Single channel analysis of Ca2+ channel-agonistic action of dihydropyridine derivatives: voltage-dependent effects of YC-170 and BAY K 8644].
    Takeda Y.
    Hokkaido Igaku Zasshi; 1993 Jul 29; 68(4):557-69. PubMed ID: 7687975
    [Abstract] [Full Text] [Related]

  • 17. Interaction of three structurally distinct Ca2+ channel activators with single L-type Ca2+ channels.
    Lauven M, Handrock R, Müller A, Hofmann F, Herzig S.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug 29; 360(2):122-8. PubMed ID: 10494880
    [Abstract] [Full Text] [Related]

  • 18. Kinetic effects of FPL 64176 on L-type Ca2+ channels in cardiac myocytes.
    Fan JS, Yuan Y, Palade P.
    Naunyn Schmiedebergs Arch Pharmacol; 2000 May 29; 361(5):465-76. PubMed ID: 10832599
    [Abstract] [Full Text] [Related]

  • 19. The selective potentiation of noradrenaline-induced tone by Bay K 8644 in the rabbit basilar artery.
    Laher I, Germann P, Dowd AL, Bevan JA.
    J Cereb Blood Flow Metab; 1989 Dec 29; 9(6):759-64. PubMed ID: 2479650
    [Abstract] [Full Text] [Related]

  • 20. Cav1.2 channel current block by the PKA inhibitor H-89 in rat tail artery myocytes via a PKA-independent mechanism: Electrophysiological, functional, and molecular docking studies.
    Fusi F, Trezza A, Spiga O, Sgaragli G, Bova S.
    Biochem Pharmacol; 2017 Sep 15; 140():53-63. PubMed ID: 28583845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.